Inventor
KAUFMAN DANIEL L
US18 patents
⚠️ This page may combine multiple inventors who share the name “KAUFMAN DANIEL L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV CALIFORNIA
17 patentsUS6682906B1Jan 27, 2004
Cloned glutamic acid decarboxylase
UNIV CALIFORNIA44 citations96
US6455267B1Sep 24, 2002
Methods and kits useful for determining the status of and detecting pancreatic B-cell associated autoimmune diseases
UNIV CALIFORNIA43 citations96
US6277586B1Aug 21, 2001
Cloned glutamic acid decarboxylase
UNIV CALIFORNIA38 citations96
US6011139AJan 4, 2000
Hybridomas and monoclonal antibodies that specifically bind to glutamic acid decarboxylase peptides
UNIV CALIFORNIA43 citations96
US5998366ADec 7, 1999
Method for ameliorating glutamic acid decarboxylase associated autoimmune disorders
UNIV CALIFORNIA63 citations96
US5846740ADec 8, 1998
Methods and kits useful for detecting autoantibody to glutamic acid decarboxylase
UNIV CALIFORNIA80 citations96
US5705626AJan 6, 1998
Cloned glutamic acid decarboxylase nucleic acids
UNIV CALIFORNIA44 citations96
US5674978AOct 7, 1997
Peptides derived from glutamic acid decarboxylase
UNIV CALIFORNIA49 citations94
US5475086ADec 12, 1995
Cloned glutamic acid decarboxylase peptides
UNIV CALIFORNIA43 citations94
US6350769B1Feb 26, 2002
Gaba alpha receptors mediate inhibition of T cell responses
UNIV CALIFORNIA23 citations92
US6022697AFeb 8, 2000
Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus
UNIV CALIFORNIA20 citations92
US10434078B2Oct 8, 2019
GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes
UNIV CALIFORNIA5 citations83
US6207159B1Mar 27, 2001
Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus
UNIV CALIFORNIA12 citations73
US11872200B2Jan 16, 2024
GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes
UNIV CALIFORNIA2 citations72
US10952980B2Mar 23, 2021
GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes
UNIV CALIFORNIA2 citations72
US7329511B2Feb 12, 2008
Nucleic acid encoding GAD65
UNIV CALIFORNIA0 citations52
US7553484B2Jun 30, 2009
Modulating neuronal outgrowth via the major histocompatibility complex class I (MHC I) molecule
UNIV CALIFORNIA5 citations51